ATE456799T1 - Verfahren zum identifizieren von präneoplastischen und neoplastischen stadien in säugern - Google Patents

Verfahren zum identifizieren von präneoplastischen und neoplastischen stadien in säugern

Info

Publication number
ATE456799T1
ATE456799T1 AT00918600T AT00918600T ATE456799T1 AT E456799 T1 ATE456799 T1 AT E456799T1 AT 00918600 T AT00918600 T AT 00918600T AT 00918600 T AT00918600 T AT 00918600T AT E456799 T1 ATE456799 T1 AT E456799T1
Authority
AT
Austria
Prior art keywords
neoplastic
mammals
identifying
preneoplastic
neoplastic stages
Prior art date
Application number
AT00918600T
Other languages
English (en)
Inventor
Michael Slater
Julian Barden
Original Assignee
Biosceptre Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosceptre Int Ltd filed Critical Biosceptre Int Ltd
Application granted granted Critical
Publication of ATE456799T1 publication Critical patent/ATE456799T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/5759—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds localised on the membrane of tumour or cancer cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT00918600T 1999-04-21 2000-04-26 Verfahren zum identifizieren von präneoplastischen und neoplastischen stadien in säugern ATE456799T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP9911A AUPP991199A0 (en) 1999-04-21 1999-04-21 Methods for diagnosing pre-cancerous and cancerous conditions
PCT/AU2000/000363 WO2001006259A1 (en) 1999-04-21 2000-04-26 A method for identifying pre-neoplastic and/or neoplastic states in mammals

Publications (1)

Publication Number Publication Date
ATE456799T1 true ATE456799T1 (de) 2010-02-15

Family

ID=3814111

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00918600T ATE456799T1 (de) 1999-04-21 2000-04-26 Verfahren zum identifizieren von präneoplastischen und neoplastischen stadien in säugern

Country Status (14)

Country Link
US (3) US7183064B1 (de)
EP (1) EP1179183B1 (de)
JP (1) JP4633984B2 (de)
KR (1) KR100819395B1 (de)
CN (1) CN100557445C (de)
AT (1) ATE456799T1 (de)
AU (2) AUPP991199A0 (de)
CA (1) CA2371163A1 (de)
DE (1) DE60043775D1 (de)
DK (1) DK1179183T3 (de)
ES (1) ES2340137T3 (de)
NO (1) NO331018B1 (de)
WO (1) WO2001006259A1 (de)
ZA (1) ZA200108616B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP991199A0 (en) * 1999-04-21 1999-05-13 University Of Sydney, The Methods for diagnosing pre-cancerous and cancerous conditions
AUPR201500A0 (en) * 2000-12-11 2001-01-11 Biosceptre Pty Ltd Methods for identifying pre-neoplastic and neoplastic states in mammals
CA2434490C (en) * 2001-01-17 2014-06-03 Intreat Pty Limited Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions
JP2010505426A (ja) * 2006-10-10 2010-02-25 バイオスセプター インターナショナル リミテッド 非機能性ｐ２ｘ７受容体に対する抗体を産生するハイブリドーマ
CA2737126C (en) 2007-09-14 2018-05-01 Biosceptre International Limited Novel p2x7 epitopes
AU2013238152B2 (en) * 2007-09-14 2015-09-24 Biosceptre International Limited Purinergic (P2X) receptors in extra-cellular body fluid
JP5624885B2 (ja) * 2007-09-14 2014-11-12 バイオセプター・インターナショナル・リミテッド 細胞外体液中のプリン作動性（ｐ２ｘ）受容体
ES2610225T3 (es) 2008-07-04 2017-04-26 Biosceptre (Aust) Pty Ltd Péptidos y epítopos anti P2X7
DK2370465T3 (da) * 2008-12-19 2019-05-06 Ablynx Nv Genetisk immunisering til fremstilling af immunoglobuliner mod celleassocierede antigener, såsom p2x7, cxcr7 eller cxcr4
ES2557456T3 (es) 2009-08-20 2016-01-26 Biosceptre (Aust) Pty Ltd Anticuerpos anti-receptor P2X7 y fragmentos de los mismos
AU2010336032C1 (en) 2009-12-24 2016-04-21 Biosceptre International Limited Antibodies to non-functional oligomeric P2X7 receptors
CN106310245A (zh) 2010-09-10 2017-01-11 生物权威(澳大利亚)有限责任公司 陪伴动物治疗
US9566318B2 (en) 2011-07-01 2017-02-14 Biosceptre (Aust) Pty Ltd Combination therapy
JP2017515473A (ja) * 2014-05-02 2017-06-15 メディミューン リミテッド イオンチャネルモジュレーターおよびその使用
WO2017041143A1 (en) 2015-09-11 2017-03-16 Ctm@Crc Ltd. Chimeric antigen receptors and uses thereof
EP3528789A4 (de) 2016-10-21 2020-06-24 Biosceptre UK Limited Zytotoxische teilchen

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE920765A1 (en) * 1991-03-12 1992-09-23 Scripps Research Inst Cell surface receptors homologous to coagulation factors v¹and viii
JP3084982B2 (ja) * 1992-11-25 2000-09-04 富士電機株式会社 半導体装置
EP0760850A1 (de) 1994-05-27 1997-03-12 Glaxo Group Limited P2x REZEPTOREN (PURINOCEPTORENFAMILIE)
CA2228999A1 (en) * 1995-08-09 1997-02-20 Institut National De La Sante Et De La Recherche Medicale Isolated nucleic acid molecules useful as leukemia markers and in breast cancer prognosis
EP0907729A1 (de) 1996-04-30 1999-04-14 Smithkline Beecham Plc Splicevarianten des menschlichen p2x4 rezeptors
US6303338B1 (en) * 1996-08-16 2001-10-16 Human Genome Sciences, Inc. Pancreas-derived plasminogen activator inhibitor
JP3885177B2 (ja) 1997-03-26 2007-02-21 大塚製薬株式会社 ヒト遺伝子
US6133434A (en) * 1997-04-28 2000-10-17 Glaxo Group Limited Purinergic receptor
DE19829473C2 (de) * 1998-07-01 2000-08-10 Magnus Von Knebel Doeberitz Ch Verfahren zur frühen Diagnose von Carcinomen
AUPP991199A0 (en) * 1999-04-21 1999-05-13 University Of Sydney, The Methods for diagnosing pre-cancerous and cancerous conditions
AUPR201500A0 (en) * 2000-12-11 2001-01-11 Biosceptre Pty Ltd Methods for identifying pre-neoplastic and neoplastic states in mammals
CA2434490C (en) * 2001-01-17 2014-06-03 Intreat Pty Limited Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions

Also Published As

Publication number Publication date
US20110111431A1 (en) 2011-05-12
CA2371163A1 (en) 2001-01-25
EP1179183B1 (de) 2010-01-27
CN100557445C (zh) 2009-11-04
KR100819395B1 (ko) 2008-04-04
NO331018B1 (no) 2011-09-12
JP4633984B2 (ja) 2011-02-16
EP1179183A4 (de) 2003-01-22
US7183064B1 (en) 2007-02-27
ES2340137T3 (es) 2010-05-31
AU779845B2 (en) 2005-02-17
NO20015157L (no) 2001-12-21
US20070248963A1 (en) 2007-10-25
HK1044190A1 (en) 2002-10-11
AU3949000A (en) 2001-02-05
AUPP991199A0 (en) 1999-05-13
WO2001006259A1 (en) 2001-01-25
DE60043775D1 (de) 2010-03-18
EP1179183A1 (de) 2002-02-13
DK1179183T3 (da) 2010-05-25
ZA200108616B (en) 2002-06-13
CN1355886A (zh) 2002-06-26
KR20020022651A (ko) 2002-03-27
NO20015157D0 (no) 2001-10-22
JP2003504643A (ja) 2003-02-04

Similar Documents

Publication Publication Date Title
ATE456799T1 (de) Verfahren zum identifizieren von präneoplastischen und neoplastischen stadien in säugern
ATE350131T1 (de) Verfahren zur behandlung von fluida
DE69812316D1 (de) Verfahren zum Einschneiden von bestehenden Rohrleitungen, Rohrleitungen, und Verfahren zum Einsatz von Ventilen in Rohrleitungen
DE69909702D1 (de) Verfahren zum Erhärten Stahlwerksslacke sowie damit hergestelltes Material
DE69418818D1 (de) Verfahren zur Ortung von Rohrverbindungen im Bohrloch
DE69939945D1 (de) Verfahren zur isolierung von stammzellen
DE69525369D1 (de) Kontinuierliches polymerisationverfahren von polyamiden
ATE230487T1 (de) Verfahren zur frühen diagnose von carcinomen
ATE321088T1 (de) Polysiloxanpolymere, verfahren zu ihrer herstellung und ihre verwendung
DE69823347D1 (de) Mikrofluidisches system und verfahren zu dessen betrieb
DE60107681D1 (de) Vaskuläre vorrichtung zum zusammenbringen von ventilklappen
DE69939312D1 (de) Verfahren zur identifizierung von induktoren und inhibitoren proteolytischer antikörper, zusammensetzungen sowie deren verwendungen
DE69822348D1 (de) R. b. yun s verfahren zur ausbeutung von tagebaulagerstätten
ATE428803T1 (de) Expression von p2y-purinergem rezeptor zur identifizierung präneoplastischer und neoplastischer zustände
ATE348043T1 (de) Verfahren zum fördern von beuteln.
DE69615339D1 (de) Verfahren zum nachweis des endogenen thrombin-potentials und thrombin substrate zur verwendung in diesen verfahren
ATE126830T1 (de) Verfahren zum nachweis von kleinzelligem carzinom und die verwendung von sequenzen, die acylpeptid- hydrolase codieren, für diesen zweck.
DE68917154D1 (de) C-terminus-amidierungsenzym-zusammensetzung, verfahren zur herstellung und verwendung.
ATE408832T1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
DE69802099D1 (de) Mikromonochromator und verfahren für dessen herstellung
DE50309796D1 (de) Verfahren zum immunzytologischen oder molekularen nachweis von disseminierten tumorzellen aus einer körperflüssigkeit und dazu geeigneter kit
PT1127133E (pt) Polipeptido que proporciona permeabilidade celular
DE69627655D1 (de) Schneidelement, stopfen und verfahren zur verhinderung des eindringens von spül-schlamm in das schneidelement
DE60216416D1 (de) Verfahren zum nachweis von chloralhydrat in dichloressigsäure
DK1208213T3 (da) Fremgangsmåde til fremstilling af proteiner i værtsceller under anvendelse af chaperoniner

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1179183

Country of ref document: EP